40
Participants
Start Date
January 31, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
BYM338
BYM338
Placebo
BYM338 Placebo
Novartis Investigative Site, Miami
Novartis Investigative Site, Miami
Novartis Investigative Site, Hot Springs
Novartis Investigative Site, Little Rock
Novartis Investigative Site, Brighton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY